Sign in
Taking people in United StatesNo phase

Program to improve treatment of high cholesterol and inherited lipid disorders

Tests a care program that helps adults with inherited high cholesterol receive lipid treatment.

Key facts

Who runs it
Atlantic Health System
Where
Clark and Springfield, United StatesSee the 2 sites
Trial code
Registry title
Atlantic Lipid Lowering Treatment Optimization Program
Status
Recruiting
People taking part
250 people, planned
Started
1 Jul 2024
Expected to end
31 Dec 2027
Type of study
Interventional
Treatments tested
  • Supportive care
Record updated
3 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with high cholesterol or other blood fat problems who are at high risk of heart disease. They get coordinated care through their primary care doctor.

Age
18 to 120 years
Sex
All sexes can join.
Disease stage
High LDL-C (bad cholesterol), high triglycerides, elevated Lp(a) or high calcium scores, or a personal or family history of coronary artery disease (CAD), or a prior heart attack (MI) without optimized lipid-lowering therapy.
Earlier treatment
People with a prior heart attack must currently not be on optimized lipid-lowering therapy. For some, LDL-C and triglycerides must be untreated.
Biomarker or test result
LDL-C 160 mg/dL (4.1 mmol/L) or more; untreated LDL-C 190 or more with a family history of CAD; untreated triglycerides above 500; elevated Lp(a) and/or high calcium scores.

Main reasons for not taking part

  • Pregnant people
  • People who are incarcerated
  • People with a terminal illness
  • People who do not consent

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • LDL-C ≥160 mg/dL
  • Untreated LDL-C ≥190 with family history of CAD
  • Prior MI and currently without optimized lipid-lowering therapy
  • Family history of CAD in first degree relative
  • Personal history of CAD
  • Untreated triglycerides >500
  • Elevated Lp(a) and/or high calcium scores
  • Consenting individuals

Who cannot take part

  • Individuals with a terminal illness
  • Individuals who are pregnant
  • Individuals who are incarcerated
  • Individuals who do not consent

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 120 years old?

Where in United States

  • Atlantic Medical GroupClark, United StatesContact: Robert D Fishberg, MDNot yet recruiting
  • Atlantic Medical GroupSpringfield, United StatesContact: Robert D Fishberg, MDTaking people

About the trial

What the trial wants to find out

Hypercholesterolemia is recognized as the major driver for cardiovascular morbidity and mortality. To help address this in our community, Atlantic Medical Group (AMG) formed a lipid workgroup chaired by Robert D. Fishberg, MD, and Jeffrey N. Feldman, MD. The overarching goal of the lipid workgroup is to enhance the treatment of lipid disorders in those patients with abnormal lipid levels by improving access to resources at the primary care practice level and specialty level. We aim to develop a model for primary and secondary prevention that integrates guidelines for treatment at the practice level. Our primary objective is to identify high-risk patients by utilizing the electronic health record and partnering with patients' primary care providers to provide comprehensive medical management.

The group in the trial

  • LDL-COther group

    Most recent LDL-C result

    Treatment: Supportive care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Complex Dyslipidemias
Plain-language title
Program to improve treatment of high cholesterol and inherited lipid disordersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06439654, who can take part
Record updated
3 August 2025